US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cognition Therapeutics, Inc

0.3724

-0.0008-0.21%

Post-market: 0.39000.0176+4.73%19:50 EDT

Volume:276.82K

Turnover:104.89K

Market Cap:23.08M

PE:-0.43

High:0.3964

Open:0.3964

Low:0.3599

Close:0.3732

Loading ...

Overview Company News Filings

Buy Recommendation for Cognition Therapeutics: Promising Phase 2 Results and Strategic Focus on Alzheimer’s and Dementia Indications

Cognition Therapeutics Earnings Call: Progress Amid Challenges

Cognition Therapeutics Inc (CGTX) Q4 2024 Earnings Call Highlights: Strategic Focus on ...

Cognition Therapeutics Advances Alzheimer’s and DLB Trials

Cognition Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Cognition Therapeutics FY 2024 EPS $(0.86) Misses $(0.76) Estimate

Cognition Therapeutics FY Net Income USD -33.971 Million

THOMSON REUTERS

Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update

THOMSON REUTERS

Press Release: Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results

Cognition Therapeutics to Present at Life Sciences Virtual Investor Conference

Cognition Therapeutics Publishes Research Supporting the Potential of Zervimesine in Dry AMD

Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study

Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit

Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit

Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)

B. Riley Adjusts Cognition Therapeutics Price Target to $2 From $1.50, Maintains Buy Rating

MT Newswires Live

Cognition Therapeutics price target raised to $2 from $1.50 at B. Riley

Director Makes Bold Move with Major Stock Purchase in Cognition Therapeutics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CGTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGTX\",,,,,undefined,":{"symbol":"CGTX","market":"US","secType":"STK","nameCN":"Cognition Therapeutics, Inc","latestPrice":0.3724,"timestamp":1744920000000,"preClose":0.3732,"halted":0,"volume":276816,"hourTrading":{"tag":"盘后","latestPrice":0.39,"preClose":0.3724,"latestTime":"19:50 EDT","volume":3807,"amount":1475.6049,"timestamp":1744933809696},"delay":0,"floatShares":55626916,"shares":61972946,"eps":-0.859999,"marketStatus":"Closed Good Friday","change":-0.0008,"latestTime":"04-17 16:00:00 EDT","open":0.3964,"high":0.3964,"low":0.3599,"amount":104887.12149696,"amplitude":0.097803,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.859999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1633665600000,"exchange":"NASDAQ","adjPreClose":0.3732,"preHourTrading":{"tag":"盘前","latestPrice":0.4089,"preClose":0.3732,"latestTime":"09:10 EDT","volume":52072,"amount":21129.4845568,"timestamp":1744895442963},"postHourTrading":{"tag":"盘后","latestPrice":0.39,"preClose":0.3724,"latestTime":"19:50 EDT","volume":3807,"amount":1475.6049,"timestamp":1744933809696},"volumeRatio":0.7401521160971245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGTX\",,,,,undefined,":{"symbol":"CGTX","floatShares":55626916,"roa":"-103.15%","roe":"-157.19%","lyrEps":-0.855043,"volumeRatio":0.7401521160971245,"shares":61972946,"dividePrice":0,"high":0.3964,"amplitude":0.097803,"preClose":0.3732,"low":0.3599,"week52Low":0.3051,"pbRate":"1.23","week52High":2.95,"institutionHeld":0,"latestPrice":0.3724,"eps":-0.859999,"divideRate":0,"volume":276816,"delay":0,"ttmEps":-0.859999,"open":0.3964,"prevYearClose":0.7013,"prevWeekClose":0.3529,"prevMonthClose":0.4208,"prevQuarterClose":0.4208,"fiveDayClose":0.3194,"twentyDayClose":0.4267,"sixtyDayClose":0.7693},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522620380","title":"Buy Recommendation for Cognition Therapeutics: Promising Phase 2 Results and Strategic Focus on Alzheimer’s and Dementia Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2522620380","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522620380?lang=en_us&edition=fundamental","pubTime":"2025-03-25 14:35","pubTimestamp":1742884555,"startTime":"0","endTime":"0","summary":"Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Cognition Therapeutics (CGTX – Research Report). The associated price ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-recommendation-for-cognition-therapeutics-promising-phase-2-results-and-strategic-focus-on-alzheimers-and-dementia-indications?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-recommendation-for-cognition-therapeutics-promising-phase-2-results-and-strategic-focus-on-alzheimers-and-dementia-indications?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4139","CGTX"],"gpt_icon":0},{"id":"2521649532","title":"Cognition Therapeutics Earnings Call: Progress Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2521649532","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521649532?lang=en_us&edition=fundamental","pubTime":"2025-03-22 08:23","pubTimestamp":1742603032,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics, Inc. (($CGTX)) has held its Q4 earnings call. Read on for the main highlights of the call. Cognition Therapeutics, Inc. rec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-earnings-call-progress-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-earnings-call-progress-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","PRGS","CGTX"],"gpt_icon":0},{"id":"2521213574","title":"Cognition Therapeutics Inc (CGTX) Q4 2024 Earnings Call Highlights: Strategic Focus on ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2521213574","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521213574?lang=en_us&edition=fundamental","pubTime":"2025-03-21 15:01","pubTimestamp":1742540508,"startTime":"0","endTime":"0","summary":"Cash and Cash Equivalents: Approximately $25 million as of December 31, 2024.Total Obligated Grant Funds: $50 million remaining from the NIA.Research and Development Expenses: $41.7 million for the year ended December 31, 2024, up from $37.2 million in 2023.General and Administrative Expenses: $12.3 million for the year ended December 31, 2024, down from $13.5 million in 2023.Net Loss: $34 million or $0.86 per basic and diluted share for the year ending December 31, 2024, compared to a net loss of $25.8 million or $0.86 per share in 2023.ATM Facility Proceeds: Sold almost 20 million shares for gross proceeds of approximately $12.8 million.GuruFocus has detected 2 Warning Signs with CGTX.Cognition Therapeutics Inc  reported strong efficacy signals from studies on zervimesine for Alzheimer's and dementia with Lewy bodies , indicating potential value for patients and investors.Cognition Therapeutics Inc  has developed a novel chemical process for manufacturing zervimesine, with provisiona","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cognition-therapeutics-inc-cgtx-q4-070148926.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CGTX"],"gpt_icon":0},{"id":"2521444276","title":"Cognition Therapeutics Advances Alzheimer’s and DLB Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2521444276","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521444276?lang=en_us&edition=fundamental","pubTime":"2025-03-21 12:04","pubTimestamp":1742529885,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics, Inc. ( ($CGTX) ) has released its Q4 earnings. Here is a breakdown of the information Cognition Therapeutics, Inc. presente...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-advances-alzheimers-and-dlb-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cognition-therapeutics-advances-alzheimers-and-dlb-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4097","LU0348723411.USD","LU0345774631.USD","LENZ","CGTX","LU0205193047.USD","LU0345774391.USD","LU0205194284.USD","DLB","LU0240878834.USD","LU0240877869.USD","BK4139"],"gpt_icon":0},{"id":"2520454248","title":"Cognition Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2520454248","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520454248?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:32","pubTimestamp":1742477532,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryCognition Therapeutics Inc CGTX.OQ reported a quarterly adjusted loss of 17 cents per share for the quart","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nL8N3Q31EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX"],"gpt_icon":0},{"id":"2520437417","title":"Cognition Therapeutics FY 2024 EPS $(0.86) Misses $(0.76) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2520437417","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520437417?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:05","pubTimestamp":1742468748,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics FY 2024 EPS $(0.86) Misses $(0.76) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44413286/cognition-therapeutics-fy-2024-eps-0-86-misses-0-76-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","LENZ"],"gpt_icon":0},{"id":"2520375884","title":"Cognition Therapeutics FY Net Income USD -33.971 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2520375884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520375884?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:00","pubTimestamp":1742468426,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nPLX2B40A5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CGTX"],"gpt_icon":0},{"id":"2520372437","title":"Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520372437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520372437?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:00","pubTimestamp":1742468426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUAZBGJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CGTX"],"gpt_icon":0},{"id":"2520437923","title":"Press Release: Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520437923","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520437923?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:00","pubTimestamp":1742468400,"startTime":"0","endTime":"0","summary":"Positive Results with Zervimesine  in Phase 2 SHIMMER Dementia with Lewy Bodies . Phase 2 SHINE Data Show Dramatic Slowing of Cognitive Decline with Zervimesine in a Key Pre-specified Alzheimer's Disease Subgroup. 2025 Objective: Advance Zervimesine into Late-stage Trials for DLB and Alzheimer's Disease. Data readouts in 2024 from the Company's Phase 2 studies in mild-to-moderate Alzheimer's disease and dementia with Lewy bodies  support the potential of zervimesine  in these patient populations. The Company reprioritized its clinical focus in 2025, concluding enrollment in the Phase 2 dry AMD clinical study in order to devote resources to support the planned registrational programs for Alzheimer's and DLB, and extend the cash runway into the fourth quarter of 2025.Next steps for zervimesine include end-of-Phase 2 meetings with the U.S. Food and Drug Administration  to align on plans for Phase 3 clinical protocols for both indications. The company plans to request separate end-of-Phase","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4554","LU2264538146.SGD","LU1852331112.SGD","BK4139","LU2360106780.USD","LU0823421416.USD","LU0056508442.USD","LU0082616367.USD","LU0719512351.SGD","LU2458330169.SGD","LU0889565833.HKD","LU1880398471.USD","LU0109392836.USD","LU0823421333.USD","DLB","BK4588","LU0642271901.SGD","LU0240877869.USD","LU0390134368.USD","IE00BMPRXR70.SGD","BK4585","BK4566","BK4097","LU0348723411.USD","LU0979878070.USD","BK4614","BK4529","BK4532","LU1064131342.USD","LU2458330243.SGD","BK4612","BK4605","LENZ","CGTX","IE00BMPRXN33.USD","IE0009356076.USD","BK4512","LU1988902786.USD","LU0127658192.USD","LU0205193047.USD","IE0004445239.USD","LU1242518857.USD","LU1880398554.USD","BK4575","LU0345774631.USD","LU1923623000.USD","LU2054465674.USD","LU2098885051.SGD","LU2250418816.HKD"],"gpt_icon":1},{"id":"2519806034","title":"Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806034","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806034?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:35","pubTimestamp":1741955700,"startTime":"0","endTime":"0","summary":"NEW YORK, March 14, 2025  -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor Forum, held March 13th are now available for online viewing.The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may downloadinvestor materials from the company’s resource section.Select companies are accepting 1x1 management meeting requests through March 18th.Virtual Investor Conferences  is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance thei","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/life-science-virtual-investor-forum-123500525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IZOZF","PDSB","TSYW.SI","TNXP","BK4007","USJW.SI","FBLG","HMTXF","CGTX","MNQmain","TQQQ","COCP","BK4179","LADX","QID",".IXIC","NQmain","BK4139","NGENF","SQQQ","QLD","FET","PSQ","TELIF","USAW.SI","AVCNF","NVIW.SI"],"gpt_icon":1},{"id":"2519486996","title":"Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2519486996","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519486996?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:05","pubTimestamp":1741896300,"startTime":"0","endTime":"0","summary":"Conference Call and Live Audio Webcast Scheduled for March 20, 2025PURCHASE, N.Y., March  13, 2025  (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/13/3042599/0/en/Cognition-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2024-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348723411.USD","BK4139","LU0345774631.USD","LU0240878834.USD","LU0345774391.USD","DLB","LU0205193047.USD","LU0205194284.USD","BK4097","LU0240877869.USD","BK4007","LENZ","CGTX"],"gpt_icon":0},{"id":"2518240276","title":"Cognition Therapeutics to Present at Life Sciences Virtual Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2518240276","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518240276?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:30","pubTimestamp":1741606200,"startTime":"0","endTime":"0","summary":"PURCHASE, N.Y., March  10, 2025  (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing product candidates that treat neur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039641/0/en/Cognition-Therapeutics-to-Present-at-Life-Sciences-Virtual-Investor-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","CGTX","DLB","BK4139","LU0205193047.USD","LU0205194284.USD","LU0240877869.USD","BK4007","LU0345774391.USD","BK4097","LENZ","LU0240878834.USD","LU0348723411.USD"],"gpt_icon":0},{"id":"2514809905","title":"Cognition Therapeutics Publishes Research Supporting the Potential of Zervimesine in Dry AMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2514809905","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514809905?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:30","pubTimestamp":1740659400,"startTime":"0","endTime":"0","summary":"Collaborators at the University of Southampton, UK and Cognition Scientists Show Rescue of Function in a Cell Model of Dry AMDPURCHASE, N.Y., Feb.  27, 2025  (GLOBE NEWSWIRE) -- Cognition Therapeutics","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033753/0/en/Cognition-Therapeutics-Publishes-Research-Supporting-the-Potential-of-Zervimesine-in-Dry-AMD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BMPRXN33.USD","BK4141","LU1852331112.SGD","LU1064131342.USD","GFS","LU2360106780.USD","CGTX","LU0823434740.USD","BK4534","LU1316542783.SGD","LU1303367103.USD","LU1951198990.SGD","LENZ","LU0345774391.USD","BK4139","LU0198837287.USD","LU2250418816.HKD","LU2458330169.SGD","LU2264538146.SGD","LU0127658192.USD","LU1880398471.USD","LU1242518931.SGD","BK4543","LU0240878834.USD","BK4585","LU0642271901.SGD","IE0004445239.USD","BK4554","BK4532","IE00BMPRXR70.SGD","LU0081259029.USD","LU2098885051.SGD","LU0082616367.USD","LU1803068979.SGD","LU1951200564.SGD","LU0719512351.SGD","LU1880398554.USD","LU0979878070.USD","BK4007","BK4529","LU0823434583.USD","LU2054465674.USD","DLB","CSF","LU0345774631.USD","LU0240877869.USD","LU1989764664.SGD","LU2458330243.SGD","LU1988902786.USD"],"gpt_icon":1},{"id":"2514983473","title":"Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514983473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514983473?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:33","pubTimestamp":1740573228,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) reported a positive outcome of an analysis of masked data from the ongoing ‘MAGNIFY’ Phase 2 trial of zervimesine in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-passes-pre-defined-futility-analysis-of-phase-2-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-passes-pre-defined-futility-analysis-of-phase-2-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2514995770","title":"Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2514995770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514995770?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:02","pubTimestamp":1740488539,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) announced that Mary Hamby, PhD will be co-hosting a precision medicine workshop at the Hanson Wade Neuroimmunology Dr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-vp-co-hosting-workshop-at-neuroimmunology-drug-development-summit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-vp-co-hosting-workshop-at-neuroimmunology-drug-development-summit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SMMF","BK4211","CGTX","BK4007"],"gpt_icon":0},{"id":"2514264095","title":"Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2514264095","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514264095?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:30","pubTimestamp":1740486600,"startTime":"0","endTime":"0","summary":"PITTSBURGH, Feb. 25, 2025  -- Cognition Therapeutics, Inc.,  , a clinical-stage company developing drugs that treat neurodegenerative disorders, today announced that Mary Hamby, PhD will be co-hosting a precision medicine workshop at the Hanson Wade Neuroimmunology Drug Development Summit. The workshop will review methods of screening participants for clinical trials to ensure that the patients selected are most likely to benefit from treatment.Dr. Hamby will present an overview of the findings from Cognition’s Phase 2 ‘SHINE’ study of zervimesine  in adults with mild-to-moderate Alzheimer’s disease. Participants with lower levels of a protein called p-tau217 at the beginning of the SHINE study experienced a robust response to zervimesine treatment. Specifically, these individuals with lower p-tau217 levels scored 95% better on the ADAS-Cog 11 scale and 108% better on the MMSE scale than did their counterparts on placebo.Forward-Looking Statements This press release contains forward-lo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cognition-therapeutics-vp-research-co-123000803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","LU0345774391.USD","DLB","LU0348723411.USD","BK4211","LU0205193047.USD","LU0345774631.USD","BK4097","SMMF","LU0205194284.USD","LU0240877869.USD","LU0240878834.USD","BK4007","CGTX","BK4139"],"gpt_icon":0},{"id":"2512441455","title":"Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)","url":"https://stock-news.laohu8.com/highlight/detail?id=2512441455","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512441455?lang=en_us&edition=fundamental","pubTime":"2025-02-20 20:30","pubTimestamp":1740054600,"startTime":"0","endTime":"0","summary":"- Chemical process enhances room temperature stability -. PURCHASE, N.Y., Feb. 20, 2025  -- Cognition Therapeutics, Inc.,  , a clinical-stage company developing drugs that treat neurodegenerative disorders, today announced that the American Chemical Society journal Organic Process Research & Development has published a manuscript describing the novel chemical process used to manufacture zervimesine . With this new manufacturing process, Cognition will be able to produce materials for future clinical studies of zervimesine. In addition, if zervimesine is approved, this process is expected to support commercial manufacturing needs.Provisional patent applications covering this chemical process and a preferred polymorphic form of zervimesine have been filed.About Cognition Therapeutics, Inc.Cognition Therapeutics, Inc., is a clinical-stage biopharmaceutical company discovering and developing innovative, small molecule therapeutics targeting age-related degenerative disorders of the CNS. We","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cognition-therapeutics-announces-publication-commercial-123000600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0348723411.USD","LENZ","CGTX","BK4135","LU0205193047.USD","BK4139","BK4097","DLB","LU0205194284.USD","LU0240878834.USD","CNS","LU0240877869.USD","LU0345774391.USD","BK4007","LU0345774631.USD"],"gpt_icon":0},{"id":"2509029277","title":"B. Riley Adjusts Cognition Therapeutics Price Target to $2 From $1.50, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2509029277","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509029277?lang=en_us&edition=fundamental","pubTime":"2025-02-06 23:06","pubTimestamp":1738854397,"startTime":"0","endTime":"0","summary":"Cognition Therapeutics (CGTX) has an average rating of Buy and mean price target of $7.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RILY","LENZ","CGTX"],"gpt_icon":0},{"id":"2509279398","title":"Cognition Therapeutics price target raised to $2 from $1.50 at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2509279398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509279398?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:50","pubTimestamp":1738849808,"startTime":"0","endTime":"0","summary":"B. Riley raised the firm’s price target on Cognition Therapeutics (CGTX) to $2 from $1.50 and keeps a Buy rating on the shares. The firm updated it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-price-target-raised-to-2-from-1-50-at-b-riley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognition-therapeutics-price-target-raised-to-2-from-1-50-at-b-riley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGTX","LENZ","RILY"],"gpt_icon":0},{"id":"2509544370","title":"Director Makes Bold Move with Major Stock Purchase in Cognition Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2509544370","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509544370?lang=en_us&edition=fundamental","pubTime":"2025-02-05 10:05","pubTimestamp":1738721156,"startTime":"0","endTime":"0","summary":"New insider activity at Cognition Therapeutics ( ($CGTX) ) has taken place on February 5, 2025. Director Lisa Ricciardi has made a significant inve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/director-makes-bold-move-with-major-stock-purchase-in-cognition-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/director-makes-bold-move-with-major-stock-purchase-in-cognition-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","CGTX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":62,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-20","symbol":"CGTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2024-11-13","symbol":"CGTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2024-08-08","symbol":"CGTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2024-05-07","symbol":"CGTX","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2024-03-26","symbol":"CGTX","fiscalQuarterEnding":"2023/12","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711425600000,"reportTimeType":"pre","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1738123200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGTX","date":"2025-04-17","current":-0.680825,"percent":0.907341,"low":-56.313627,"twenty":-3.721199,"median":-2.436234,"eighty":-0.953167,"high":-0.458398,"avg":-5.770084,"sd":10.695544,"marketCap":23128303},"quantilePoints":[{"date":"2021-10-08","current":-54.318634,"twenty":-53.008521,"median":-51.043352,"eighty":-51.043352,"marketCap":267573589},{"date":"2021-10-15","current":-51.628056,"twenty":-52.877541,"median":-52.429288,"eighty":-51.277234,"marketCap":254319802},{"date":"2021-10-22","current":-52.061905,"twenty":-52.877541,"median":-52.319436,"eighty":-51.801596,"marketCap":256456944},{"date":"2021-10-29","current":-52.452369,"twenty":-52.782095,"median":-52.474061,"eighty":-52.061905,"marketCap":258380371},{"date":"2021-11-05","current":-52.148675,"twenty":-52.955634,"median":-52.495754,"eighty":-52.061905,"marketCap":256884372},{"date":"2021-11-12","current":-50.933897,"twenty":-52.999019,"median":-52.582524,"eighty":-52.061905,"marketCap":250900376},{"date":"2021-11-19","current":-36.38032,"twenty":-52.955634,"median":-52.495754,"eighty":-51.043352,"marketCap":227195098},{"date":"2021-11-26","current":-31.475505,"twenty":-52.903572,"median":-52.365599,"eighty":-46.578051,"marketCap":196564527},{"date":"2021-12-03","current":-29.323032,"twenty":-52.790772,"median":-52.10529,"eighty":-35.646362,"marketCap":183122334},{"date":"2021-12-10","current":-28.405584,"twenty":-52.756064,"median":-52.061905,"eighty":-31.172041,"marketCap":177392875},{"date":"2021-12-17","current":-18.525381,"twenty":-52.747387,"median":-51.043352,"eighty":-29.591209,"marketCap":115691005},{"date":"2021-12-23","current":-21.736447,"twenty":-52.712679,"median":-50.456663,"eighty":-29.181886,"marketCap":135744113},{"date":"2021-12-31","current":-22.30103,"twenty":-52.625909,"median":-38.074069,"eighty":-22.30103,"marketCap":139269934},{"date":"2022-01-07","current":-20.289703,"twenty":-52.625909,"median":-35.921596,"eighty":-22.054025,"marketCap":126709196},{"date":"2022-01-14","current":-22.054025,"twenty":-52.539139,"median":-31.475505,"eighty":-22.054025,"marketCap":137727387},{"date":"2022-01-21","current":-12.350254,"twenty":-52.504431,"median":-31.12264,"eighty":-21.708218,"marketCap":77127337},{"date":"2022-01-28","current":-12.244395,"twenty":-52.495754,"median":-29.975831,"eighty":-21.073062,"marketCap":76466245},{"date":"2022-02-04","current":-15.56132,"twenty":-52.461046,"median":-29.323032,"eighty":-20.106214,"marketCap":97180444},{"date":"2022-02-11","current":-14.149862,"twenty":-52.382953,"median":-28.793735,"eighty":-17.974913,"marketCap":88365891},{"date":"2022-02-18","current":-11.609239,"twenty":-52.328669,"median":-25.018086,"eighty":-15.554263,"marketCap":72499696},{"date":"2022-02-25","current":-10.233068,"twenty":-52.216979,"median":-24.312357,"eighty":-14.904992,"marketCap":63905507},{"date":"2022-03-04","current":-8.856896,"twenty":-52.096613,"median":-22.35396,"eighty":-14.432154,"marketCap":55311318},{"date":"2022-03-11","current":-9.492052,"twenty":-52.061905,"median":-22.054025,"eighty":-12.98541,"marketCap":59277867},{"date":"2022-03-18","current":-10.550646,"twenty":-52.061905,"median":-22.054025,"eighty":-12.597259,"marketCap":65888782},{"date":"2022-03-25","current":-10.515359,"twenty":-51.801596,"median":-21.736447,"eighty":-11.524551,"marketCap":65668418},{"date":"2022-04-01","current":-5.010611,"twenty":-51.277234,"median":-21.20715,"eighty":-10.74825,"marketCap":58704318},{"date":"2022-04-08","current":-6.032005,"twenty":-51.043352,"median":-20.677854,"eighty":-10.451844,"marketCap":70670967},{"date":"2022-04-14","current":-5.588758,"twenty":-50.99957,"median":-20.32499,"eighty":-10.275412,"marketCap":65477893},{"date":"2022-04-22","current":-6.070548,"twenty":-50.55211,"median":-19.33697,"eighty":-9.449708,"marketCap":71122539},{"date":"2022-04-29","current":-5.342796,"twenty":-48.27874,"median":-17.996085,"eighty":-9.287391,"marketCap":62596202},{"date":"2022-05-06","current":-5.786422,"twenty":-42.666251,"median":-15.878898,"eighty":-8.856896,"marketCap":67793721},{"date":"2022-05-13","current":-4.18241,"twenty":-37.961153,"median":-15.526034,"eighty":-6.50994,"marketCap":65985888},{"date":"2022-05-20","current":-3.938914,"twenty":-37.227195,"median":-14.855591,"eighty":-6.062092,"marketCap":62144244},{"date":"2022-05-27","current":-3.838651,"twenty":-36.013341,"median":-14.538013,"eighty":-5.911684,"marketCap":60562390},{"date":"2022-06-03","current":-3.566507,"twenty":-35.13118,"median":-14.326295,"eighty":-5.79028,"marketCap":56268788},{"date":"2022-06-10","current":-2.750078,"twenty":-33.338629,"median":-13.214772,"eighty":-5.589715,"marketCap":43387981},{"date":"2022-06-17","current":-2.377672,"twenty":-31.454333,"median":-12.844264,"eighty":-5.461433,"marketCap":37512525},{"date":"2022-06-24","current":-2.635491,"twenty":-31.369645,"median":-12.667832,"eighty":-5.323508,"marketCap":41580148},{"date":"2022-07-01","current":-3.222748,"twenty":-31.12264,"median":-12.297325,"eighty":-5.12624,"marketCap":50845290},{"date":"2022-07-08","current":-3.365981,"twenty":-30.727432,"median":-11.50338,"eighty":-4.150899,"marketCap":53105081},{"date":"2022-07-15","current":-2.878988,"twenty":-30.233422,"median":-10.832937,"eighty":-3.861568,"marketCap":45421793},{"date":"2022-07-22","current":-3.036544,"twenty":-29.880558,"median":-10.638862,"eighty":-3.746982,"marketCap":47907562},{"date":"2022-07-29","current":-2.707108,"twenty":-29.591209,"median":-10.480073,"eighty":-3.577966,"marketCap":42710044},{"date":"2022-08-05","current":-4.4832,"twenty":-29.365376,"median":-10.374213,"eighty":-3.555048,"marketCap":70731448},{"date":"2022-08-12","current":-2.561319,"twenty":-29.266574,"median":-10.162495,"eighty":-3.489161,"marketCap":51326263},{"date":"2022-08-19","current":-2.334653,"twenty":-29.196001,"median":-9.456765,"eighty":-3.268697,"marketCap":46784116},{"date":"2022-08-26","current":-2.334653,"twenty":-28.560844,"median":-9.350907,"eighty":-3.151131,"marketCap":46784116},{"date":"2022-09-02","current":-2.130654,"twenty":-27.812772,"median":-9.20976,"eighty":-3.036544,"marketCap":42696183},{"date":"2022-09-09","current":-2.096655,"twenty":-26.076679,"median":-8.892183,"eighty":-2.98689,"marketCap":42014861},{"date":"2022-09-16","current":-1.983322,"twenty":-24.615821,"median":-8.751037,"eighty":-2.936281,"marketCap":39743788},{"date":"2022-09-23","current":-1.892656,"twenty":-24.326472,"median":-6.533066,"eighty":-2.878988,"marketCap":37926929},{"date":"2022-09-30","current":-2.153321,"twenty":-23.423139,"median":-6.128363,"eighty":-2.844612,"marketCap":43150398},{"date":"2022-10-07","current":-2.187321,"twenty":-22.576265,"median":-6.04423,"eighty":-2.724296,"marketCap":43831720},{"date":"2022-10-14","current":-2.062655,"twenty":-22.343374,"median":-5.954918,"eighty":-2.618303,"marketCap":41333539},{"date":"2022-10-21","current":-1.937989,"twenty":-22.173999,"median":-5.832135,"eighty":-2.511452,"marketCap":38835358},{"date":"2022-10-28","current":-2.209987,"twenty":-22.06814,"median":-5.762203,"eighty":-2.37906,"marketCap":44285935},{"date":"2022-11-04","current":-2.028655,"twenty":-22.054025,"median":-5.59115,"eighty":-2.341453,"marketCap":40652217},{"date":"2022-11-11","current":-1.908266,"twenty":-22.054025,"median":-5.554965,"eighty":-2.293854,"marketCap":38239736},{"date":"2022-11-18","current":-1.80798,"twenty":-22.054025,"median":-5.41764,"eighty":-2.243987,"marketCap":42585160},{"date":"2022-11-25","current":-3.050198,"twenty":-21.969337,"median":-5.333152,"eighty":-2.243987,"marketCap":71844352},{"date":"2022-12-02","current":-3.456071,"twenty":-21.799962,"median":-5.222598,"eighty":-2.243987,"marketCap":81404286},{"date":"2022-12-09","current":-2.819045,"twenty":-21.679989,"median":-5.141318,"eighty":-2.251626,"marketCap":66399786},{"date":"2022-12-16","current":-2.737629,"twenty":-21.454155,"median":-4.4832,"eighty":-2.264513,"marketCap":64482102},{"date":"2022-12-23","current":-2.904609,"twenty":-21.214208,"median":-4.168087,"eighty":-2.264513,"marketCap":68415151},{"date":"2022-12-30","current":-2.584609,"twenty":-21.171864,"median":-4.117955,"eighty":-2.266654,"marketCap":60877889},{"date":"2023-01-06","current":-2.781532,"twenty":-21.171864,"median":-3.953237,"eighty":-2.266654,"marketCap":65516204},{"date":"2023-01-13","current":-2.732301,"twenty":-20.677854,"median":-3.838651,"eighty":-2.289838,"marketCap":64356625},{"date":"2023-01-20","current":-2.498456,"twenty":-20.508479,"median":-3.795681,"eighty":-2.307557,"marketCap":58848626},{"date":"2023-01-27","current":-2.486148,"twenty":-20.353219,"median":-3.716902,"eighty":-2.321053,"marketCap":58558731},{"date":"2023-02-03","current":-2.609225,"twenty":-20.29676,"median":-3.580831,"eighty":-2.332386,"marketCap":61457678},{"date":"2023-02-10","current":-2.289225,"twenty":-19.555745,"median":-3.53786,"eighty":-2.332386,"marketCap":53920416},{"date":"2023-02-17","current":-2.215379,"twenty":-19.315798,"median":-3.509214,"eighty":-2.289715,"marketCap":52181047},{"date":"2023-02-24","current":-1.864611,"twenty":-18.835902,"median":-3.408951,"eighty":-2.266654,"marketCap":43919048},{"date":"2023-03-03","current":-2.079995,"twenty":-18.207803,"median":-3.294436,"eighty":-2.243987,"marketCap":48992205},{"date":"2023-03-10","current":-2.087168,"twenty":-17.932569,"median":-3.197788,"eighty":-2.24239,"marketCap":49161146},{"date":"2023-03-17","current":-2.211404,"twenty":-16.725773,"median":-3.151131,"eighty":-2.225141,"marketCap":52087404},{"date":"2023-03-24","current":-2.653148,"twenty":-15.864783,"median":-3.136292,"eighty":-2.218944,"marketCap":56769418},{"date":"2023-03-31","current":-2.707853,"twenty":-15.660122,"median":-3.098992,"eighty":-2.225141,"marketCap":57939922},{"date":"2023-04-06","current":-2.502712,"twenty":-15.547206,"median":-3.050198,"eighty":-2.229674,"marketCap":53550534},{"date":"2023-04-14","current":-2.448008,"twenty":-15.427232,"median":-3.036544,"eighty":-2.23559,"marketCap":52380030},{"date":"2023-04-21","current":-2.297572,"twenty":-15.208456,"median":-2.985617,"eighty":-2.241592,"marketCap":49161146},{"date":"2023-04-28","current":-2.33977,"twenty":-14.904992,"median":-2.950605,"eighty":-2.243987,"marketCap":50064065},{"date":"2023-05-05","current":-2.285039,"twenty":-14.608586,"median":-2.920445,"eighty":-2.241592,"marketCap":48892975},{"date":"2023-05-12","current":-1.960622,"twenty":-14.580357,"median":-2.893311,"eighty":-2.217756,"marketCap":46527513},{"date":"2023-05-19","current":-2.467425,"twenty":-14.523899,"median":-2.871827,"eighty":-2.205838,"marketCap":58554454},{"date":"2023-05-26","current":-2.430413,"twenty":-14.432154,"median":-2.858289,"eighty":-2.210554,"marketCap":57676137},{"date":"2023-06-02","current":-3.071944,"twenty":-14.291008,"median":-2.850341,"eighty":-2.212199,"marketCap":72900295},{"date":"2023-06-09","current":-3.701137,"twenty":-13.994602,"median":-2.864665,"eighty":-2.216567,"marketCap":87831681},{"date":"2023-06-16","current":-3.6888,"twenty":-13.310045,"median":-2.878988,"eighty":-2.222594,"marketCap":87538908},{"date":"2023-06-23","current":-3.269338,"twenty":-13.055983,"median":-2.893311,"eighty":-2.227687,"marketCap":77584651},{"date":"2023-06-30","current":-2.158997,"twenty":-12.914837,"median":-2.893311,"eighty":-2.226414,"marketCap":51235147},{"date":"2023-07-07","current":-1.961603,"twenty":-12.858379,"median":-2.878988,"eighty":-2.210837,"marketCap":46550790},{"date":"2023-07-14","current":-2.220682,"twenty":-12.759576,"median":-2.864665,"eighty":-2.20302,"marketCap":52699008},{"date":"2023-07-21","current":-2.134322,"twenty":-12.681946,"median":-2.850341,"eighty":-2.185861,"marketCap":50649602},{"date":"2023-07-28","current":-2.072637,"twenty":-12.561973,"median":-2.826229,"eighty":-2.183671,"marketCap":49185741},{"date":"2023-08-04","current":-2.183671,"twenty":-12.406712,"median":-2.808868,"eighty":-2.180597,"marketCap":51820691},{"date":"2023-08-11","current":-2.24283,"twenty":-12.286739,"median":-2.785721,"eighty":-2.183671,"marketCap":50923457},{"date":"2023-08-18","current":-2.029227,"twenty":-11.863301,"median":-2.744609,"eighty":-2.168944,"marketCap":46073604},{"date":"2023-08-25","current":-2.029227,"twenty":-11.482208,"median":-2.736692,"eighty":-2.147762,"marketCap":46073604},{"date":"2023-09-01","current":-2.069278,"twenty":-11.334005,"median":-2.721529,"eighty":-2.134322,"marketCap":46982952},{"date":"2023-09-07","current":-2.029227,"twenty":-11.291661,"median":-2.717274,"eighty":-2.134322,"marketCap":46073604},{"date":"2023-09-13","current":-1.922426,"twenty":-11.016427,"median":-2.715721,"eighty":-2.130654,"marketCap":43648678},{"date":"2023-09-22","current":-1.708823,"twenty":-10.804708,"median":-2.707853,"eighty":-2.110595,"marketCap":38798824},{"date":"2023-09-28","current":-1.788924,"twenty":-10.755307,"median":-2.702213,"eighty":-2.099254,"marketCap":40617519},{"date":"2023-10-05","current":-1.828975,"twenty":-10.727078,"median":-2.692436,"eighty":-2.087168,"marketCap":41526867},{"date":"2023-10-11","current":-1.802274,"twenty":-10.621219,"median":-2.686743,"eighty":-2.085321,"marketCap":40920635},{"date":"2023-10-20","current":-1.695473,"twenty":-10.543589,"median":-2.684528,"eighty":-2.080991,"marketCap":38495709},{"date":"2023-10-27","current":-1.49522,"twenty":-10.536531,"median":-2.683071,"eighty":-2.079135,"marketCap":33948971},{"date":"2023-11-03","current":-1.361718,"twenty":-10.508302,"median":-2.666389,"eighty":-2.072637,"marketCap":30917813},{"date":"2023-11-10","current":-1.332388,"twenty":-10.480073,"median":-2.653148,"eighty":-2.069278,"marketCap":30417082},{"date":"2023-11-17","current":-1.332388,"twenty":-10.423615,"median":-2.646148,"eighty":-2.06131,"marketCap":30417082},{"date":"2023-11-24","current":-1.345712,"twenty":-10.4095,"median":-2.628512,"eighty":-2.052945,"marketCap":30721252},{"date":"2023-11-30","current":-1.425655,"twenty":-10.395385,"median":-2.607276,"eighty":-2.048349,"marketCap":32546277},{"date":"2023-12-07","current":-1.812047,"twenty":-10.353042,"median":-2.598444,"eighty":-2.042577,"marketCap":41367231},{"date":"2023-12-14","current":-2.345003,"twenty":-10.338927,"median":-2.595483,"eighty":-2.042577,"marketCap":53534064},{"date":"2024-01-05","current":-2.771916,"twenty":-10.275412,"median":-2.592521,"eighty":-2.045808,"marketCap":63280072},{"date":"2024-01-12","current":-2.842269,"twenty":-10.190724,"median":-2.607276,"eighty":-2.047962,"marketCap":64886165},{"date":"2024-01-19","current":-3.236247,"twenty":-10.035464,"median":-2.628512,"eighty":-2.048736,"marketCap":73880287},{"date":"2024-01-26","current":-3.194035,"twenty":-9.703771,"median":-2.653148,"eighty":-2.050467,"marketCap":72916631},{"date":"2024-02-02","current":-3.222177,"twenty":-9.463823,"median":-2.665604,"eighty":-2.051322,"marketCap":73559068},{"date":"2024-02-09","current":-3.165894,"twenty":-9.39325,"median":-2.683071,"eighty":-2.052945,"marketCap":72274194},{"date":"2024-02-16","current":-2.785987,"twenty":-9.350907,"median":-2.688118,"eighty":-2.055599,"marketCap":63601290},{"date":"2024-02-23","current":-2.828199,"twenty":-9.350907,"median":-2.696348,"eighty":-2.057273,"marketCap":64564946},{"date":"2024-03-01","current":-2.912622,"twenty":-9.329735,"median":-2.707853,"eighty":-2.062655,"marketCap":66492258},{"date":"2024-03-08","current":-2.771916,"twenty":-9.230932,"median":-2.7149,"eighty":-2.06398,"marketCap":63280072},{"date":"2024-03-15","current":-2.5285,"twenty":-9.125073,"median":-2.714167,"eighty":-2.069278,"marketCap":57723128},{"date":"2024-03-22","current":-2.684756,"twenty":-8.913354,"median":-2.707853,"eighty":-2.069278,"marketCap":61290288},{"date":"2024-03-28","current":-2.288672,"twenty":-8.856896,"median":-2.702213,"eighty":-2.069278,"marketCap":59020277},{"date":"2024-04-05","current":-2.918811,"twenty":-8.856896,"median":-2.707853,"eighty":-2.072637,"marketCap":75270293},{"date":"2024-04-12","current":-3.160785,"twenty":-8.751037,"median":-2.716454,"eighty":-2.072637,"marketCap":81510317},{"date":"2024-04-19","current":-2.7827,"twenty":-8.504032,"median":-2.721529,"eighty":-2.072637,"marketCap":71760279},{"date":"2024-04-26","current":-2.918811,"twenty":-6.648695,"median":-2.734028,"eighty":-2.073988,"marketCap":75270293},{"date":"2024-05-03","current":-3.074207,"twenty":-6.417436,"median":-2.737629,"eighty":-2.078562,"marketCap":79277655},{"date":"2024-05-10","current":-2.658425,"twenty":-6.321078,"median":-2.741119,"eighty":-2.079995,"marketCap":76474910},{"date":"2024-05-17","current":-2.70148,"twenty":-6.128363,"median":-2.73733,"eighty":-2.084974,"marketCap":77713486},{"date":"2024-05-24","current":-3.620541,"twenty":-6.070548,"median":-2.741119,"eighty":-2.085321,"marketCap":104152094},{"date":"2024-05-31","current":-2.743256,"twenty":-6.059274,"median":-2.744609,"eighty":-2.085321,"marketCap":78915241},{"date":"2024-06-07","current":-2.548304,"twenty":-6.036895,"median":-2.743256,"eighty":-2.085321,"marketCap":73307051},{"date":"2024-06-14","current":-3.063534,"twenty":-5.997316,"median":-2.744609,"eighty":-2.086429,"marketCap":88128695},{"date":"2024-06-21","current":-2.840732,"twenty":-5.966481,"median":-2.750078,"eighty":-2.089222,"marketCap":81719335},{"date":"2024-06-28","current":-2.325501,"twenty":-5.958772,"median":-2.750078,"eighty":-2.091276,"marketCap":66897691},{"date":"2024-07-05","current":-2.464753,"twenty":-5.911684,"median":-2.744609,"eighty":-2.094508,"marketCap":70903541},{"date":"2024-07-12","current":-2.548304,"twenty":-5.868281,"median":-2.740443,"eighty":-2.096384,"marketCap":73307051},{"date":"2024-07-15","current":-2.757181,"twenty":-5.863421,"median":-2.743256,"eighty":-2.09652,"marketCap":79315826},{"date":"2024-08-02","current":-1.253264,"twenty":-5.858561,"median":-2.740443,"eighty":-2.095978,"marketCap":36052648},{"date":"2024-08-09","current":-0.753562,"twenty":-5.80571,"median":-2.735755,"eighty":-2.085321,"marketCap":23422203},{"date":"2024-08-16","current":-0.828948,"twenty":-5.786422,"median":-2.729518,"eighty":-2.078562,"marketCap":25765360},{"date":"2024-08-23","current":-0.979372,"twenty":-5.762203,"median":-2.717274,"eighty":-2.072637,"marketCap":30440850},{"date":"2024-08-30","current":-0.916749,"twenty":-5.593541,"median":-2.71552,"eighty":-2.062655,"marketCap":28494402},{"date":"2024-09-06","current":-0.785693,"twenty":-5.593541,"median":-2.714787,"eighty":-2.054568,"marketCap":24420906},{"date":"2024-09-13","current":-0.779366,"twenty":-5.589715,"median":-2.714099,"eighty":-2.047962,"marketCap":24224255},{"date":"2024-09-20","current":-0.786855,"twenty":-5.577154,"median":-2.70748,"eighty":-2.041187,"marketCap":24457026},{"date":"2024-09-27","current":-0.52939,"twenty":-5.558823,"median":-2.70018,"eighty":-2.029227,"marketCap":16454514},{"date":"2024-10-04","current":-0.561541,"twenty":-5.551165,"median":-2.692436,"eighty":-2.027934,"marketCap":17453824},{"date":"2024-10-11","current":-0.528099,"twenty":-5.461433,"median":-2.685985,"eighty":-2.017322,"marketCap":16414381},{"date":"2024-10-18","current":-0.575357,"twenty":-5.404682,"median":-2.680114,"eighty":-1.999884,"marketCap":17883247},{"date":"2024-10-25","current":-0.761677,"twenty":-5.353445,"median":-2.666389,"eighty":-1.984892,"marketCap":23674433},{"date":"2024-10-31","current":-0.685625,"twenty":-5.331223,"median":-2.659705,"eighty":-1.983322,"marketCap":21310602},{"date":"2024-11-08","current":-0.67168,"twenty":-5.309214,"median":-2.653148,"eighty":-1.978496,"marketCap":20877166},{"date":"2024-11-15","current":-0.599125,"twenty":-5.253433,"median":-2.64578,"eighty":-1.966526,"marketCap":20532022},{"date":"2024-11-22","current":-0.515042,"twenty":-5.213707,"median":-2.633673,"eighty":-1.956102,"marketCap":17650476},{"date":"2024-11-29","current":-0.487374,"twenty":-5.187226,"median":-2.619731,"eighty":-1.937989,"marketCap":16702293},{"date":"2024-12-06","current":-0.458398,"twenty":-5.144334,"median":-2.609225,"eighty":-1.922426,"marketCap":15709296},{"date":"2024-12-13","current":-0.616612,"twenty":-5.079988,"median":-2.598985,"eighty":-1.90713,"marketCap":21131310},{"date":"2024-12-20","current":-0.768644,"twenty":-4.799647,"median":-2.592521,"eighty":-1.866762,"marketCap":26341428},{"date":"2024-12-27","current":-0.930374,"twenty":-4.449963,"median":-2.590079,"eighty":-1.848993,"marketCap":31883931},{"date":"2025-01-03","current":-0.876666,"twenty":-4.317013,"median":-2.584832,"eighty":-1.825371,"marketCap":30043355},{"date":"2025-01-10","current":-0.953652,"twenty":-4.209331,"median":-2.584609,"eighty":-1.806839,"marketCap":32681652},{"date":"2025-01-17","current":-0.84175,"twenty":-4.17244,"median":-2.560657,"eighty":-1.775574,"marketCap":28846772},{"date":"2025-01-24","current":-0.953046,"twenty":-4.160238,"median":-2.557163,"eighty":-1.730183,"marketCap":32660878},{"date":"2025-01-31","current":-0.931466,"twenty":-4.14517,"median":-2.548304,"eighty":-1.695473,"marketCap":31921324},{"date":"2025-02-07","current":-0.775797,"twenty":-4.113658,"median":-2.535095,"eighty":-1.682123,"marketCap":26586562},{"date":"2025-02-14","current":-0.7153,"twenty":-4.019124,"median":-2.52911,"eighty":-1.620963,"marketCap":24513317},{"date":"2025-02-21","current":-0.739062,"twenty":-3.959688,"median":-2.5285,"eighty":-1.507172,"marketCap":25327657},{"date":"2025-02-28","current":-0.55563,"twenty":-3.944293,"median":-2.516839,"eighty":-1.437461,"marketCap":19041446},{"date":"2025-03-07","current":-0.522896,"twenty":-3.910267,"median":-2.502712,"eighty":-1.402377,"marketCap":17919650},{"date":"2025-03-14","current":-0.503134,"twenty":-3.855839,"median":-2.492302,"eighty":-1.377689,"marketCap":17242417},{"date":"2025-03-21","current":-0.521872,"twenty":-3.827192,"median":-2.467425,"eighty":-1.352114,"marketCap":17728529},{"date":"2025-03-28","current":-0.822207,"twenty":-3.804275,"median":-2.463143,"eighty":-1.332388,"marketCap":27931206},{"date":"2025-04-04","current":-0.704176,"twenty":-3.778493,"median":-2.449225,"eighty":-1.016109,"marketCap":23921557},{"date":"2025-04-11","current":-0.582678,"twenty":-3.741252,"median":-2.44554,"eighty":-0.978985,"marketCap":19794158},{"date":"2025-04-17","current":-0.680825,"twenty":-3.721199,"median":-2.436234,"eighty":-0.953167,"marketCap":23128303}],"updateTime":1744966639364}}}